article thumbnail

Oxford Cannabinoid Technologies Holdings plc – Pre-Close Trading Update; US OTC QB Market Application & Notice of 2021 Final Results

Cannabis Law Report

Oxford Cannabinoid Technologies Holdings plc. In parallel, OCTP has signed multi-site, multi-disciplinary in vitro and in vivo work-packages with CRO Eurofins to enable OCT461201 indication expansion into neuropathic disorders. Pre-Close Trading Update; US OTC QB Market Application. & & Notice of 2021 Final Results. .

article thumbnail

States Have Made Over $15B From Cannabis Tax Revenue Despite Decline

Veriheal

Since the state-legal, adult-use cannabis market began in 2014, a combined total of more than $15 billion has been generated in tax revenue. The widespread availability of untaxed intoxicating synthetic cannabinoids gotten from hemp is also believed to have contributed to the decline. The revenue generated in 2022 alone was $3.77

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lazarus Naturals Launches Its New Sleep Collection Introducing CBN

Cannabis Law Report

New product line features alternative cannabinoids like CBG and CBN, in addition to effective, functional ingredients for healthy sleeping habits. The three cannabinoids combined team up to help promote deep relaxation, relief from muscle pain, and a sense of calm. CBN is a powerful cannabinoid that is becoming increasingly popular.

Sleep 105
article thumbnail

Tilray Announces Launch of New Medical Cannabis Brand, Symbios

Cannabis Law Report

(“Tilray”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced the launch of Symbios, a complement to the Company’s existing medical brand portfolio in Canada. Aphria started in 2014 in Leamington, Ontario, as one of the first companies to provide access to legal, medical cannabis.

Topical 102
article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.

article thumbnail

United States: Hemp And CBD Regulation: Beyond Delta-8 THC

Cannabis Law Report

… and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers … with a delta-9 tetrahydrocannabinol [THC] concentration of not more than 0.3 Enforcement falls, for the most part, to states like New York, who have moved on their own to regulate hemp derived cannabinoids. ” See 7 U.S.C.

THC 105
article thumbnail

Hemp CBD Across State Lines: North Carolina

Canna Law Blog

Currently, NCDA is operating under the 2014 Farm Bill, not the 2018 Farm Bill. SB 315 would grant NCDA the ability to “regulate cannabinoid related compounds” which would not include smokable hemp. NCDA would oversee good manufacturing practices for manufacturing, packaging, labeling, or holding operations for Hemp CBD.

Hemp 103